Abstract:Objective:To evaluate the effect of calcium channel blocker (CCB) amlodipine combined with larger dose of angiotensin Ⅱ type 1 receptor blocker (ARB) valsartan on improving left ventricular diastolic dysfunction (LVDD) in postmenopausal hypertensive women patients with left ventricular hypertrophy (LVH).Methods:This prospective, open parallel controlled study enrolled 103 natural postmenopausal women patients aged 45-65 years with hypertension and LVH who presented in Lanzhou University Second Hospital from December 2016 to April 2017. Patients were divided into group A and group B. The former group was given amlodipine (5 mg/d) plus higher dose of valsartan (160~320 mg/d), and the latter group was given amlodipine (5 mg/d) plus valsartan (80 mg/d). All patients were followed up for 18 months. The serum biochemical indexes, renin angiotensin system (RAS) components, type Ⅰ and type Ⅲ collagen, 8-hydroxy- deoxyguanosine (8-OHdG), superoxide dismutase (SOD), glutathione (GSH) and α-smooth muscle actin (α-SMA) were detected before and after treatment of 18 months. Moreover, mean 24-hour ambulatory blood pressure, load value and coefficient of variation, and ambulatory arterial stiffness index (AASI) were evaluated. Cardiac structure, systolic and diastolic function were assessed by echocardiography.Results:(1) There were no significant differences in clinical characteristics between the two groups when enrolled (all P>0.05). (2) Patients on both group have reached the target blood pressure on 24-hour ambulatory blood pressure monitoring without significant difference. However, the AASI level of group A after treatment was lower than that before treatment and group B after treatment (all P<0.05). (3) There were no significant differences in oxidative stress and myocardial fibrosis parameters between the two groups before and after treatment (all P>0.05). (4) After 18 months of treatment, angiotensin (1-7), angiotensin (1-9) and angiotensin converting enzyme 2 (ACE2) were increased while ACE levels were decreased significantly (all P<0.05) in the group A, whereas only angiotensin (1-7) increased in the group B ( P<0.05). (5) The interventricular septum thickness at end-diastole and left ventricular mass decreased, the ratio of early diastolic peak flow velocity (E) to early diastolic mitral annular velocity (e′) (E/e′) decreased and the ratio of e′ to late diastolic mitral annular velocity (a′) (e′/a′) increased significantly (all P<0.05), indicating the improvement of LVDD in the group A, while no similar changes were observed in the group B. (6) The occurrence of adverse events was similar between the two groups (all P>0.05). Conclusion:CCB combined with a larger dose of ARB can improve the LVDD of postmenopausal women patients with hypertension and LVH to a certain extent.

Calcium channel blocker-based combination regimen to prevent cardiac hypertrophy in patients with hypertension

Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia

Efficacy and Safety of the Compound of Candesartan Cilexetial and Hydrochlorothiazide in Patients with Essential Hypertension

Effects of Combination Treatment with Perindopril and Losartan on Left Ventricular Remodeling and Cardiac Function in Patients with Myocardial Infarction

Effect of Different Combined Antihypertensive Regimen on the Erectile Function in Malehypertensive Patients

575 Combined Antihypertensive Regimen, Sexual Function, Oxidative Stress and Hypertension

The effect of combined antihypertensive treatment (felodipine with either irbesartan or metoprolol) on erectile function: a randomized controlled trial.

Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca 2+ -ATPase activity in rat cardiac pressure-overload hypertrophy

Combined Antihypertensive Regimen, Sexual Function, Oxidative Stress And Hypertension: A Randomized Controlled Trial

Combination Of Amlodipine With Diuretics Or Telmisartan In High-Risk Hypertensive Patients: The Chinese Hypertension Intervention Efficacy Study (Chief)

Efficacy, Safety and Tolerance of Felodipine Controlled Release Tablets and Felodipine Controlled Release Tablets Associated Combination Therapy in the Treatment of Mild to Moderate Essential Hypertension in China

Comparison of efficacy and tolerability of felodipine ER monotherapy and combined felodipine ER and losartan in patients with essential hypertension

Effect of felodipine with irbesartan or metoprolol on sexual function and oxidative stress in women with essential hypertension.

Effects of Felodipine on Endothelial Function and Atherosclerosis Progression of Large Arteries and Left Ventricular Hypertrophy in Hypertensive Patients

525 4 YEARS OUTCOME OF AMLODIPINE PLUS TELMISARTAN OR AMLODIPINE PLUS DIURETICS REGIMEN ON CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS 13542

The Efficacy and Safety of the Compound Felodipine Sustained-Release Tablets in Mild to Moderate Essential Hypertension: a Double-Blind Randomized Clinical Trials

Clinical Study on the Effect of Calcium Channel Blocker Combined with Angiotensin Ⅱ Type 1 Receptor Blocker on Left Ventricular Diastolic Dysfunction in Postmenopausal Hypertension Women Patients with Left Ventricular Hypertrophy

1073 CHANGES IN FEMALE HORMONE LEVELS UNDER DIFFERENT ANTIYPERTENSIVE COMBINATION THERAPY

Effect of nifedipine controlled released tablet and atorvastatin on carotid intimamedia thickness and vascular endothelial function in patients with hypertension

Effects of enalapril folic acid combined with levamlodipine on incidence of cardiovascular and cerebrovascular events in patients with essential hypertension

Effects of Fosinopril, Irbesartan and Combined Treatment on Ventricular Remodeling after Myocardial Infarction